4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-21-132481
Options or other derivatives
- Chief Scientific Officer acquired 243,639 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sethuraman Natarajan · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-10-28 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +243,639 | $20.00 | 2031-10-28 | 243,639 | 243,639 | D |
Loading xslF345X03/tm2131250-14_4seq1.xml…